Cogent Biosciences COGT
NASDAQ COGT
$31.02 -0.57 (-1.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) Gains from Sales and Divestitures (2019 - 2026)

Updated

Cogent Biosciences' Gains from Sales and Divestitures came in at $1,000 for Q2 2026.

Analysis

Cogent Biosciences (COGT) Gains from Sales and Divestitures (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Cogent Biosciences reported Gains from Sales and Divestitures of -$134,000; for FY2023, it was -$8,000.

  • Going back by year, Gains from Sales and Divestitures was $7.49 million in FY2020 and $78,000 in FY2019.
  • The Q2 2026 figure represents the highest quarterly Gains from Sales and Divestitures since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Cogent Biosciences 5.32 Bn 5.32 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Mar 31, 2026 -135,000.00
Dec 31, 2020 23,000.00
Sep 30, 2020 7.46 Mn
Dec 31, 2019 -4,000.00
API Access

Cogent Biosciences Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=COGT&period=max&api_key=YOUR_API_KEY